HCV in prisons: Targeting elimination
In the battle to eliminate HCV as a public health threat by 2030, prison healthcare is at the forefront.
This webinar, developed and hosted by Alchemie Medical Education, part of the Obsidian Group, brings together three international experts who lead prison-based HCV elimination programmes to share their in-depth knowledge and first-hand experience.
Through four presentations and a panel discussion, the faculty will guide you through the key things to consider when setting up HCV testing and treatment programmes in custodial settings, review international best practice and share inspiring success stories that have yielded real-world results.
Originally hosted live on 24th May 2022
SPEAKERS
 | Dr Fadi Meroueh, Prison Health Unit of Villeneuve-lès-Maguelonne, Montpellier University Hospital Center, France |
 | Rachel Halford, CEO Hepatitis Trust, UK |
 | Dr Joaquín Cabezas, Hospital Universitario Marques de Valdecilla, Cantabria, Spain |
CONTENTS
- Planning for success: Building the foundations of a microelimination programme
Dr Fadi Meroueh - Peer-led elimination
Rachel Halford - Breaking barriers
Dr Fadi Meroueh - Success stories: Elimination in action
Dr Joaquin Cabezas - Discussion and Q&A
All
This webinar was developed and hosted by Alchemie Medical Education, part of the Obsidian Group.
This webinar has been funded by an educational grant from Gilead Sciences, Inc. The sponsor had no influence on speaker selection, agenda or content.